Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Mol Cell Biol ; 21(1): 65, 2020 Sep 14.
Article in English | MEDLINE | ID: mdl-32928102

ABSTRACT

BACKGROUND: The human Obg-like ATPase 1 (OLA1) protein has been reported to play an important role in cancer cell proliferation. The molecular mechanism underlying OLA1 regulated oral metastasis is still unknown. We investigated in this study the regulatory role of OLA1 playing in oral squamous cell metastasis. RESULTS: A series of in vitro assays were performed in the cells with RNAi-mediated knockdown or overexpression to expound the regulatory function of OLA1 in oral cancer. We found that the endogenous level of OLA1 in a highly metastatic oral squamous cell line was significantly lower than that in low metastatic oral cells as well as in normal oral cells. Escalated expression of OLA1 resulted in a reduced ability of metastasis in highly metastatic cells, and enhanced its sensitivity to the paclitaxel treatment. Further analysis of the EMT markers showed that Snail, Slug, N-cadherin were up-expressed significantly. Meanwhile, E-cadherin was significantly down-regulated in the oral cancer cells with OLA1-knocked down, suggesting that OLA1 inactivated EMT process. Furthermore, we found that OLA1 suppressed oral squamous cell metastasis by suppressing the activity of a TGFß/SMAD2/EMT pathway. CONCLUSION: Our data suggests that OLA1 may be developed as a potential target for the treatment of oral cancer metastasis.


Subject(s)
Adenosine Triphosphatases/metabolism , Carcinoma/metabolism , GTP-Binding Proteins/metabolism , Mouth Neoplasms/metabolism , Neoplasm Metastasis/pathology , Smad2 Protein/metabolism , Transforming Growth Factor beta/metabolism , Cadherins/metabolism , Carcinoma/drug therapy , Carcinoma/pathology , Cell Line, Tumor , Down-Regulation/drug effects , Down-Regulation/physiology , Humans , Mouth Neoplasms/drug therapy , Mouth Neoplasms/pathology , Neoplasm Metastasis/drug therapy , Paclitaxel/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , Snail Family Transcription Factors/metabolism , Up-Regulation/drug effects , Up-Regulation/physiology
2.
Clin Oral Investig ; 22(2): 571-581, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29299731

ABSTRACT

BACKGROUND: Oral squamous cell carcinomas (OC) are life-threatening diseases emerging as major international health concerns. OBJECTIVE: Development of an efficient clinical strategy for early diagnosis of the disease is a key for reducing the death rate. Biomarkers are proven to be an effective approach for clinical diagnosis of cancer. Although mechanisms underlying regulation of oral malignancy are still unclear, microRNAs (miRNAs) as a group of small non-coded RNAs may be developed as the effective biomarkers used for early detection of oral cancer. METHODS: A literature search was conducted using the databases of PubMed, Web of Science, and the Cochrane Library. The following search terms were used: miRNAs and oral cancer or oral carcinoma. A critical appraisal of the included studies was performed with upregulated miRNAs and downregulated miRNAs in oral cancer. RESULTS: In this review, we summarize the research progress made in miRNAs for diagnosis of oral cancer. The involvement of miRNAs identified in signal transduction pathways in OC, including Ras/MAPK signaling, PI3K/AKT signaling, JAK/STAT signaling, Wnt/ß-catenin signaling, Notch signaling, and TGF-ß/SMAD signaling pathway. CONCLUSIONS: A number of studies demonstrated that miRNAs may be developed as an ideal set of biomarkers used for early diagnosis and prognosis of cancers because of the stability in human peripheral blood and body fluids and availability of non-invasive approaches being developed for clinical utility. CLINICAL RELEVANCE: These findings suggest that miRNAs as biomarkers may be useful for diagnosis of OC.


Subject(s)
Biomarkers, Tumor/metabolism , MicroRNAs/metabolism , Mouth Neoplasms/diagnosis , Mouth Neoplasms/metabolism , Early Detection of Cancer , Humans
3.
Expert Rev Mol Diagn ; 14(1): 97-106, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24308340

ABSTRACT

Cancer becomes the second leading cause of death in the world. An effective strategy for early diagnosis of the disease is key to reduce the mortality and morbidity. Development of effective monoclonal antibody (mAb)-based assays or diagnostic imaging techniques for detection of antigens and small molecules that are released from cancerous cells will enhance modern diagnostic medicine of cancer significantly. Although mAb technology is still under development, recent advances in preparation of recombinant antigen and antibody engineering techniques have dramatically enhanced the applications of this technology in cancer diagnosis. Compared with other methods, mAb-based assays may provide spatial, temporal, accurate and quantitative measurement for diagnosis of the disease. This review summarizes the progress of the mAb-based assays in the field of molecular diagnosis of cancer.


Subject(s)
Antibodies, Monoclonal , Neoplasms/diagnosis , Animals , Biomarkers, Tumor/metabolism , Early Detection of Cancer , Humans , Neoplasms/metabolism , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...